Page last updated: 2024-09-03

imatinib mesylate and Mouth Diseases

imatinib mesylate has been researched along with Mouth Diseases in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (44.44)	29.6817
2010's	5 (55.56)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dogra, S; Handa, S; Khadwal, A; Kumari, S; Lad, D; Malhotra, P; Prakash, G; Suri, V; Varma, S; Vinay, K; Yanamandra, U	1
Bailey, BM; Creedon, A; Lyne, A	1
Casado, M; Feito, M; Feltes, R; Floristán, U; Herranz, P; Mariño-Enriquez, A; Ramírez, P; Sendagorta, E	1
Gilbert, M; Klieb, HB; Sade, S; Wong, M	1
Borroni, G; Brazzelli, V; Fiandrino, G; Lucioni, M; Manna, G; Moggio, E; Muzio, F; Orlandi, E; Vassallo, C	1
Field, EA; Rajlawat, BP; Steele, JC; Triantafyllou, A	1
Lim, DS; Muir, J	1
Chiarolini, F; Cossu, A; Ena, P; Siddi, GM	1
Borras-Blasco, J; Conesa, V; Matarredona, J; Miralles, J; Pascual, JC	1

Reviews

2 review(s) available for imatinib mesylate and Mouth Diseases

Article	Year
Lichenoid drug eruption related to imatinib: report of a new case and review of the literature. Clinical and experimental dermatology, 2009, Volume: 34, Issue:7 Topics: Aged; Antineoplastic Agents; Benzamides; Drug Eruptions; Humans; Imatinib Mesylate; Lichenoid Eruptions; Male; Mouth Diseases; Piperazines; Pyrimidines	2009
Oral melanosis after tyrosine kinase inhibition with Imatinib for chronic myelogenous leukemia: report of a case and review of the literature. Dermatology online journal, 2011, May-15, Volume: 17, Issue:5 Topics: Adult; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanins; Melanosis; Mouth Diseases; Palate, Hard; Piperazines; Protein Kinase Inhibitors; Pyrimidines	2011

Article

Year

Lichenoid drug eruption related to imatinib: report of a new case and review of the literature.

Clinical and experimental dermatology, 2009, Volume: 34, Issue:7

Topics: Aged; Antineoplastic Agents; Benzamides; Drug Eruptions; Humans; Imatinib Mesylate; Lichenoid Eruptions; Male; Mouth Diseases; Piperazines; Pyrimidines

2009

Oral melanosis after tyrosine kinase inhibition with Imatinib for chronic myelogenous leukemia: report of a case and review of the literature.

Dermatology online journal, 2011, May-15, Volume: 17, Issue:5

Topics: Adult; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanins; Melanosis; Mouth Diseases; Palate, Hard; Piperazines; Protein Kinase Inhibitors; Pyrimidines

2011

Other Studies

7 other study(ies) available for imatinib mesylate and Mouth Diseases

Article	Year
Long-term mucocutaneous adverse effects of imatinib in Indian chronic myeloid leukemia patients. International journal of dermatology, 2018, Volume: 57, Issue:3 Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Cross-Sectional Studies; Drug Eruptions; Edema; Eye Diseases; Female; Humans; Hyperpigmentation; Hypopigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichenoid Eruptions; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Nail Diseases; Sex Factors; Skin Diseases, Vesiculobullous; Time Factors; Young Adult	2018
Mucosal pigmentation of the hard palate in a patient taking imatinib. BMJ case reports, 2015, Apr-16, Volume: 2015 Topics: Antineoplastic Agents; Female; Humans; Hyperpigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Mouth Diseases; Mouth Mucosa; Palate, Hard	2015
Photoinduced dermatitis and oral lichenoid reaction in a chronic myeloid leukemia patient treated with imatinib mesylate. Photodermatology, photoimmunology & photomedicine, 2012, Volume: 28, Issue:1 Topics: Antineoplastic Agents; Benzamides; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichenoid Eruptions; Middle Aged; Mouth Diseases; Photosensitivity Disorders; Piperazines; Pyrimidines; Skin Pigmentation	2012
Oral mucosal hyperpigmentation and horizontal melanonychia caused by imatinib. Clinical and experimental dermatology, 2012, Volume: 37, Issue:4 Topics: Antineoplastic Agents; Benzamides; Humans; Hyperpigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Nail Diseases; Piperazines; Protein Kinase Inhibitors; Pyrimidines	2012
Oral lichenoid reaction to imatinib (STI 571, Gleevec). Dermatology (Basel, Switzerland), 2002, Volume: 205, Issue:2 Topics: Aged; Antineoplastic Agents; Benzamides; Drug Eruptions; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichenoid Eruptions; Mouth Diseases; Piperazines; Pyrimidines	2002
Oral lichenoid eruption secondary to imatinib (Glivec). The Journal of dermatological treatment, 2004, Volume: 15, Issue:4 Topics: Antineoplastic Agents; Benzamides; Drug Eruptions; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lichenoid Eruptions; Male; Middle Aged; Mouth Diseases; Piperazines; Protein-Tyrosine Kinases; Pyrimidines	2004
Oral and cutaneous lichenoid reaction secondary to imatinib: report of two cases. International journal of dermatology, 2006, Volume: 45, Issue:12 Topics: Aged; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichenoid Eruptions; Mouth Diseases; Piperazines; Pyrimidines; Tongue Diseases	2006